2020
COVID‐19 and the heart: An update for clinicians
Goha A, Mezue K, Edwards P, Nunura F, Baugh D, Madu E. COVID‐19 and the heart: An update for clinicians. Clinical Cardiology 2020, 43: 1216-1222. PMID: 32533585, PMCID: PMC7323229, DOI: 10.1002/clc.23406.Peer-Reviewed Original ResearchConceptsPrognosis of COVID-19 diseaseAdverse cardiac effectsPre-existing cardiovascular diseaseOptimal patient managementAcute myocardial injuryRisk of morbidityAcute coronary syndromeManifestations of COVID-19Cardiovascular manifestations of COVID-19Cardiovascular manifestationsCardiac effectsEffects of medicationVenous thromboembolismCoronary syndromeHeart failureMyocardial injuryPatient managementRAA systemClinical syndromeCardiovascular diseaseViral entrySARS-CoV-2COVID-19 diseaseHeartCOVID-19
2019
Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association
Rangaswami J, Bhalla V, Blair J, Chang T, Costa S, Lentine K, Lerma E, Mezue K, Molitch M, Mullens W, Ronco C, Tang W, McCullough P, Cardiology O. Cardiorenal Syndrome: Classification, Pathophysiology, Diagnosis, and Treatment Strategies: A Scientific Statement From the American Heart Association. Circulation 2019, 139: e840-e878. PMID: 30852913, DOI: 10.1161/cir.0000000000000664.Peer-Reviewed Original ResearchConceptsCardiorenal syndromeChronic dysfunctionPathogenesis of cardiorenal syndromeHeart-kidney interactionsKidney transplant recipientsSpectrum of disordersTransplant recipientsDiabetes mellitusNeurohormonal markersTreatment strategiesClinical phenotypeFailing heartScientific statementSyndromeClinicopathologic descriptionKidneyMolecular signaturesPatientsDysfunctionCross-talkHeartMellitusPathophysiologyPalliative carePathogenesis